Readers ’ Comments: Aspirin and/or Other Antiplatelet Agents for the Prevention of Infective Endocarditis
Infective endocarditis (IE) is a relatively rare disease with frequent fatal outcome and devastating morbidity, with a long “intubation” period, in the sense that patients harboring IE-predisposing factors (congenital and rheumatic or other acquired heart diseases with valvular abnormalities, implanted artificial and biological valves and cardiac electronic devices, etc) may develop the disease decades after exposure to such factors. Antibiotic prophylaxis (AP) is recommended prior to invasive procedures (e.g.
Source: The American Journal of Cardiology - Category: Cardiology Authors: John E. Madias Source Type: research
More News: Aspirin | Cardiology | Endocarditis | Heart | Heart Transplant | Infective Endocarditis | Rare Diseases | Rheumatology